Interstitial lung diseases (ILD) encompass a diverse group of pulmonary conditions characterized by inflammation and fibrosis of the lung interstitium. This article provides a comprehensive overview of ILD, focusing on its etiology, classification, clinical presentation, diagnosis, and management.
ILDs can be idiopathic or secondary to various factors such as occupational exposure, drugs, and systemic diseases. Based on etiology, ILDs are classified into idiopathic interstitial pneumonias, connective tissue disease-associated ILD, and occupational ILD, among others.
Patients with ILD typically present with progressive dyspnea and non-productive cough. Physical examination may reveal inspiratory crackles and finger clubbing. Hypoxemia and restrictive pattern are common findings on arterial blood gas analysis and pulmonary function tests respectively.
High-resolution computed tomography (HRCT) is the imaging modality of choice for ILD. It helps in identifying the pattern of disease which can be either usual interstitial pneumonia (UIP) or non-specific interstitial pneumonia (NSIP). Bronchoalveolar lavage and lung biopsy may be required in certain cases for definitive diagnosis.
Management of ILD is largely based on the underlying cause. In idiopathic cases, treatment is primarily supportive, including oxygen therapy and pulmonary rehabilitation. Immunosuppressive therapy may be used in cases associated with connective tissue diseases. Lung transplantation may be considered in advanced cases.
In conclusion, ILD represents a complex group of lung disorders with diverse etiology and clinical presentation. High clinical suspicion, coupled with appropriate diagnostic modalities, is key to timely diagnosis and management. As healthcare professionals, understanding the nuances of ILD is crucial for providing optimal patient care.
1.
Promising OS at 5 Years With Chemo-Free Combo in Urothelial Cancer
2.
Black Canadians Face Multiple Barriers to Blood Donation
3.
Stop Calling It Cancer; The Alcohol Paradox; Rural Patients Lose Ground in Screening
4.
Experts say oncology, primary care coordination necessary for best cancer patient outcomes
5.
Neural networks and label-free microscopy enable accurate detection of pancreatic tumors
1.
Machine Learning in Hematology: Boosting Diagnostic Precision and Speed in Medical Practice
2.
Advancing Cancer Care: Insights into Oncology Trials, Immunotherapy, and CAR-T Innovations
3.
Clinical Frameworks in Hematology for Better Care
4.
Empowering Lung Cancer Diagnosis Through the Synergy of Advanced Technologies and Artificial Intelligence
5.
The Benefits of Understanding Haptoglobin High: What You Need to Know
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion
2.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part II
3.
Newer Immunotherapies for Myeloma- A Comprehensive Overview- Part II
4.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part IV
5.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Important Points to Know
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation